Suppr
超能文献

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision.

作者信息

Schrag Deborah

机构信息

Dana Farber Cancer Institute, Boston, Massachusetts2Associate Editor, JAMA.

出版信息

JAMA. 2016 May 3;315(17):1837-8. doi: 10.1001/jama.2016.4284.

DOI:10.1001/jama.2016.4284

PMID:27139054

Abstract

摘要

相似文献

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision.

JAMA. 2016 May 3;315(17):1837-8. doi: 10.1001/jama.2016.4284.

Chemoradiation for Locally Advanced Unresectable Pancreatic Cancer-What Now?

JAMA Oncol. 2017 Jun 1;3(6):850-851. doi: 10.1001/jamaoncol.2016.3012.

Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer.

Cancer Chemother Pharmacol. 2014 Jul;74(1):205-10. doi: 10.1007/s00280-014-2488-7. Epub 2014 Jun 8.

[The results of the LAP07 trial should not be misunderstood as the end of chemoradiotherapy in pancreatic cancer].

Strahlenther Onkol. 2016 Dec;192(12):956-958. doi: 10.1007/s00066-016-1058-9.

[Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP)].

Strahlenther Onkol. 2014 Mar;190(3):319-20. doi: 10.1007/s00066-013-0533-9.

A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent.

Cancer Chemother Pharmacol. 2017 Sep;80(3):497-505. doi: 10.1007/s00280-017-3375-9. Epub 2017 Jul 12.

Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.

Eur J Cancer. 2016 Mar;55:131-9. doi: 10.1016/j.ejca.2015.11.022. Epub 2016 Jan 25.

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.

PLoS One. 2016 Jun 23;11(6):e0156910. doi: 10.1371/journal.pone.0156910. eCollection 2016.

Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.

Biomed Pharmacother. 2017 Dec;96:619-625. doi: 10.1016/j.biopha.2017.10.043. Epub 2017 Oct 13.

Maintenance therapy for metastatic colorectal cancer.

Lancet Oncol. 2015 Nov;16(15):1444-1445. doi: 10.1016/S1470-2045(15)00308-3. Epub 2015 Oct 22.

引用本文的文献

Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma.

Cancers (Basel). 2021 Oct 15;13(20):5168. doi: 10.3390/cancers13205168.

Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells - Role of Snail, Slug and Twist and Small Molecule Inhibitors.

Onco Targets Ther. 2020 Jun 18;13:5763-5777. doi: 10.2147/OTT.S253418. eCollection 2020.

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients.

Integr Cancer Ther. 2019 Jan-Dec;18:1534735419878505. doi: 10.1177/1534735419878505.

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.

J Clin Med. 2018 Jul 13;7(7):175. doi: 10.3390/jcm7070175.

"HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer.

Radiat Oncol. 2017 Nov 21;12(1):183. doi: 10.1186/s13014-017-0923-8.

Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9.

Sci Rep. 2017 Oct 30;7(1):14309. doi: 10.1038/s41598-017-14688-z.

Having Your Cake and Eating It Too: Combining SBRT and Multi-agent Chemotherapy in Locally Advanced Pancreatic Cancer.

Cureus. 2016 Jul 13;8(7):e686. doi: 10.7759/cureus.686.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译